盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期

老虎资讯综合07-31 20:18

7月31日，艾伯维公司盘前跌近4%，报247.52美元。

消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。

不过，公司同步下调全年调整后EPS指引区间至13.87至14.07美元，此前预期为13.91至14.11美元，略低于市场此前预期的14.06美元。市场关注公司在修美乐生物类似药竞争压力下，能否依靠Skyrizi、Rinvoq等核心产品维持增长动能。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1177080903?lang=zh_CN&edition=full","thumbnail":"https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c","is_english":false,"pubTime":"2026-07-31 20:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177080903","market":"us","top_or_hot":-1,"title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","media":"老虎资讯综合","content":"<html><head></head><body><p style=\"text-align: left;\">7月31日，<a href=\"https://laohu8.com/S/ABBV\">艾伯维公司</a>盘前跌近4%，报247.52美元。</p><p style=\"text-align: left;\">消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。</p><p style=\"text-align: left;\">不过，公司同步下调全年调整后EPS指引区间至13.87至14.07美元，此前预期为13.91至14.11美元，略低于市场此前预期的14.06美元。市场关注公司在修美乐生物类似药竞争压力下，能否依靠Skyrizi、Rinvoq等核心产品维持增长动能。</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/287531bb35996c4fb1ce8f1526c7d7ae\" data-align=\"center\" tg-width=\"718\" tg-height=\"220\"/><span></span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-07-31 20:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: left;\">7月31日，<a href=\"https://laohu8.com/S/ABBV\">艾伯维公司</a>盘前跌近4%，报247.52美元。</p><p style=\"text-align: left;\">消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。</p><p style=\"text-align: left;\">不过，公司同步下调全年调整后EPS指引区间至13.87至14.07美元，此前预期为13.91至14.11美元，略低于市场此前预期的14.06美元。市场关注公司在修美乐生物类似药竞争压力下，能否依靠Skyrizi、Rinvoq等核心产品维持增长动能。</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/287531bb35996c4fb1ce8f1526c7d7ae\" data-align=\"center\" tg-width=\"718\" tg-height=\"220\"/><span></span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABBV","symbol_name":"艾伯维公司","start_time":0,"source_url":"","article_id":"1177080903","we_media_id":"102","thumbnails":["https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177080903","pubTimestamp":1785500326,"columns":[{"name":"财报速递","id":26,"label_key":"express"}],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"7月31日，艾伯维公司盘前跌近4%，报247.52美元。消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ABBV":"艾伯维公司"},"translate_title":"Pre-market changes | AbbVie fell nearly 4% premarket, Q2 results exceeded expectations, full-year EPS guidance missed market expectations","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/d2a72b7caa77290dfa3b1d3b15b1a85f","symbols_score_info":{"ABBV":2.1},"content_text":"7月31日，艾伯维公司盘前跌近4%，报247.52美元。消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。不过，公司同步下调全年调整后EPS指引区间至13.87至14.07美元，此前预期为13.91至14.11美元，略低于市场此前预期的14.06美元。市场关注公司在修美乐生物类似药竞争压力下，能否依靠Skyrizi、Rinvoq等核心产品维持增长动能。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1177080903","isCrawlerRequest":true}